Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata

British Journal of Dermatology

Volumn 166, Issue 2, 2012, Pages 266-273

  Zhao, M ^a   Liang, G ^a   Wu, X ^a   Wang, S ^a   Zhang, P ^a   Su, Y ^a   Yin, H ^a   Tan, Y ^a   Zhang, J ^a   Lu, Q ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; DNA; DNA METHYLTRANSFERASE 1; GENOMIC DNA; HISTONE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 7; HISTONE H3; MESSENGER RNA; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN DERIVATIVE; PROTEIN JMJD2A; PROTEIN JMJD2B; PROTEIN KDM1A; PROTEIN KMD4B; PROTEIN LSD1; PROTEIN P300; PROTEIN SET7; PROTEIN SET9; RANTES; UNCLASSIFIED DRUG; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; E1A ASSOCIATED P300 PROTEIN; G9A PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; JHDM2A PROTEIN; JMJD2A PROTEIN; JMJD2B PROTEIN; LSD1 PROTEIN; MBD1 PROTEIN; MBD3 PROTEIN; MBD4 PROTEIN; METHYL CPG BINDING PROTEIN 2; PROTEIN; RETINOBLASTOMA BINDING PROTEIN 2; SETD1A PROTEIN; SETD7 PROTEIN; SETDB1 PROTEIN; SIRTUIN 1; SUV39H1 PROTEIN; SUV39H2 PROTEIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE;

ADULT; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; DNA MODIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FEMALE; HAIR LOSS; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; HISTONE METHYLATION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ACETYLATION; ADOLESCENT; CASE CONTROL STUDY; CHEMISTRY; GENETIC EPIGENESIS; GENETICS; METABOLISM; MODIFIER GENE; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY; REGULATOR GENE;

ACETYLATION; ADOLESCENT; ADULT; ALOPECIA AREATA; CASE-CONTROL STUDIES; CHEMOKINE CCL5; DNA METHYLATION; DNA-CYTOSINE METHYLASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIGENESIS, GENETIC; FEMALE; GENES, MODIFIER; GENES, REGULATOR; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HISTONE DEMETHYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; RNA, MESSENGER; YOUNG ADULT;

EID: 84863348879     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10646.x     Document Type: Article

References (36)

1. Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-33.
2. Todes-Taylor N, Turner R, Wood GS, et al. T cell subpopulations in alopecia areata. J Am Acad Dermatol 1984; 11: 216-23.
3. de Andrade M, Jackow CM, Dahm N, et al. Alopecia areata in families: association with the HLA locus. J Investig Dermatol Symp Proc 1999; 4: 220-3.
4. McDonagh AJ, Tazi-Ahnini R,. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002; 27: 405-9.
5. McElwee K, Freyschmidt-Paul P, Ziegler A, et al. Genetic susceptibility and severity of alopecia areata in human and animal models. Eur J Dermatol 2001; 11: 11-16.
6. McElwee KJ, Hoffmann R,. Alopecia areata-animal models. Clin Exp Dermatol 2002; 27: 410-17.
7. Petukhova L, Duvic M, Hordinsky M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466: 113-17.
8. Skinner RB Jr, Light WH, Bale GF, et al. Alopecia areata and presence of cytomegalovirus DNA. JAMA 1995; 273: 1419-20.
9. Madani S, Shapiro J,. Alopecia areata update. J Am Acad Dermatol 2000; 42: 549-66.
10. Panconesi E, Hautmann G,. Psychophysiology of stress in dermatology. The psychobiologic pattern of psychosomatics. Dermatol Clin 1996; 14: 399-421.
11. Brooks WH, Le Dantec C, Pers JO, et al. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207-19.
12. Kaplan MJ, Lu Q, Wu A, et al. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172: 3652-61.
13. Lan J, Hua S, He X, et al. DNA methyltransferases and methyl-binding proteins of mammals. Acta Biochim Biophys Sin (Shanghai) 2010; 42: 243-52.
14. Berger SL,. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002; 12: 142-8.
15. Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-7.
16. Kuwano Y, Fujimoto M, Watanabe R, et al. Serum chemokine profiles in patients with alopecia areata. Br J Dermatol 2007; 157: 466-73.
17. Gilhar A, Landau M, Assy B, et al. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Clin Immunol 2003; 106: 181-7.
18. Gilhar A, Shalaginov R, Assy B, et al. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Investig Dermatol Symp Proc 1999; 4: 207-10.
19. Ballestar E,. Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 2011; 7: 263-71.
20. Lei W, Luo Y, Lei W, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009; 38: 369-74.
21. Luo Y, Li Y, Su Y, et al. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br J Dermatol 2008; 159: 827-33.
22. Zhang P, Su Y, Chen H, et al. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J Dermatol Sci 2010; 60: 40-2.
23. Zhao M, Gao F, Wu X, et al. Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo. Br J Dermatol 2010; 163: 736-42.
24. Richardson B, Ray D, Yung R,. Murine models of lupus induced by hypomethylated T cells. Methods Mol Med 2004; 102: 285-94.
25. D'Cruz D,. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 2000; 112-113: 421-32.
26. Lu Q, Kaplan M, Ray D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282-91.
27. Luo Y, Zhang X, Zhao M, et al. DNA demethylation of the perforin promoter in CD4(+) T cells from patients with subacute cutaneous lupus erythematosus. J Dermatol Sci 2009; 56: 33-6.
28. Hendrich B, Bird A,. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18: 6538-47.
29. Grunstein M,. Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349-52.
30. Peterson CL, Laniel MA,. Histones and histone modifications. Curr Biol 2004; 14: R546-51.
31. Wang Z, Zang C, Rosenfeld JA, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40: 897-903.
32. Hu N, Qiu X, Luo Y, et al. Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 2008; 35: 804-10.
33. Hughes T, Webb R, Fei Y, et al. DNA methylome in human CD4+ T cells identifies transcriptionally repressive and non-repressive methylation peaks. Genes Immun 2010; 11: 554-60.
34. Roh TY, Cuddapah S, Cui K, et al. The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci USA 2006; 103: 15782-7.
35. Ansari KI, Mishra BP, Mandal SS,. Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. Biochim Biophys Acta 2008; 1779: 66-73.
36. Li Y, Reddy MA, Miao F, et al. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008; 283: 26771-81.